Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking
February 19, 2025
February 19, 2025
CHAPEL HILL, North Carolina, Feb. 19 -- The University of North Carolina School of Medicine issued the following news release:
* * *
Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking
Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.
The blockbuster drug semaglutide, bette . . .
* * *
Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking
Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.
The blockbuster drug semaglutide, bette . . .